| 1 | Microbial composition associated with biliary stents in patients undergoing pancreatic resection for cancer | 8.1 | 12 | Citations (PDF) |
| 2 | Optimizing abemaciclib-induced diarrhea management in patients with breast cancer: a pragmatic 2-group study using a postbiotic microbiota stabilizer | 3.5 | 4 | Citations (PDF) |
| 3 | Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia | 21.2 | 59 | Citations (PDF) |
| 4 | NaCl enhances CD8+ T cell effector functions in cancer immunotherapy | 24.2 | 39 | Citations (PDF) |
| 5 | Clinical features and management issues of NAFLD-related HCC: what we know so far | 2.5 | 10 | Citations (PDF) |
| 6 | Training the microbiota to increase immune checkpoint blockade and to reduce toxicity | 3.2 | 13 | Citations (PDF) |
| 7 | Analyzing the diffusion and duration of antibodies to SARS-CoV-2 during the natural infection and comparison with vaccination | 2.7 | 1 | Citations (PDF) |
| 8 | The intratumoral microbiota: friend or foe? | 10.6 | 33 | Citations (PDF) |
| 9 | Efficacy of Six Different SARS-CoV-2 Vaccines during a Six-Month Follow-Up and Five COVID-19 Waves in Brazil and Mexico | 3.0 | 5 | Citations (PDF) |
| 10 | Association Between Duration of SARS-CoV-2 Positivity and Long COVID | 5.4 | 8 | Citations (PDF) |
| 11 | Amplicon-Based Microbiome Profiling: From Second- to Third-Generation Sequencing for Higher Taxonomic Resolution | 2.6 | 33 | Citations (PDF) |
| 12 | A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy | 4.0 | 4 | Citations (PDF) |
| 13 | Biomimetic superabsorbent hydrogel acts as a gut protective dynamic exoskeleton improving metabolic parameters and expanding A. muciniphila | 6.7 | 13 | Citations (PDF) |
| 14 | Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors | 13.9 | 12 | Citations (PDF) |
| 15 | A ‘Multiomic’ Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019 | 0.9 | 19 | Citations (PDF) |
| 16 | mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients | 2.6 | 35 | Citations (PDF) |
| 17 | A Target Animal Effectiveness Study on Adjuvant Peptide-Based Vaccination in Dogs with Non-Metastatic Appendicular Osteosarcoma Undergoing Amputation and Chemotherapy | 4.0 | 14 | Citations (PDF) |
| 18 | BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection? | 7.2 | 36 | Citations (PDF) |
| 19 | Humoral response to anti-SARS-CoV-2 vaccine in breastfeeding mothers and mother-to-infant antibody transfer through breast milk | 5.4 | 10 | Citations (PDF) |
| 20 | Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers | 17.1 | 238 | Citations (PDF) |
| 21 | Unveiling the gut-brain axis: structural and functional analogies between the gut and the choroid plexus vascular and immune barriers | 8.3 | 39 | Citations (PDF) |
| 22 | Functional characterization and immunomodulatory properties of Lactobacillus helveticus strains isolated from Italian hard cheeses | 2.4 | 26 | Citations (PDF) |
| 23 | Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer | 12.7 | 76 | Citations (PDF) |
| 24 | Gut–Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers | 3.4 | 18 | Citations (PDF) |
| 25 | Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver | 38.5 | 430 | Citations (PDF) |
| 26 | SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy | 3.5 | 22 | Citations (PDF) |
| 27 | One dose of SARS-CoV-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic COVID-19 | 10.7 | 101 | Citations (PDF) |
| 28 | Identification of a class of non-conventional ER-stress-response-derived immunogenic peptides | 6.4 | 19 | Citations (PDF) |
| 29 | The antibody response to SARS-CoV-2 infection persists over at least 8 months in symptomatic patients | 4.6 | 13 | Citations (PDF) |
| 30 | The ocular microbiome and microbiota and their effects on ocular surface pathophysiology and disorders | 5.5 | 116 | Citations (PDF) |
| 31 | Identification of a choroid plexus vascular barrier closing during intestinal inflammation | 36.4 | 229 | Citations (PDF) |
| 32 | Biomimetic cellulose-based superabsorbent hydrogels for treating obesity | 3.5 | 14 | Citations (PDF) |
| 33 | Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1 2021, 9, e003224 | | 21 | Citations (PDF) |
| 34 | The gut-liver axis in liver disease: Pathophysiological basis for therapy | 3.6 | 1,738 | Citations (PDF) |
| 35 | Evidence for interleukin 17 involvement in severe immune-related neuroendocrine toxicity | 5.1 | 17 | Citations (PDF) |
| 36 | Analysis of immune, microbiota and metabolome maturation in infants in a clinical trial of Lactobacillus paracasei CBA L74-fermented formula | 13.9 | 72 | Citations (PDF) |
| 37 | Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth | 16.5 | 436 | Citations (PDF) |
| 38 | Consensus guidelines for the definition, detection and interpretation of immunogenic cell death 2020, 8, e000337 | | 889 | Citations (PDF) |
| 39 | Regulatory T Cells Beyond Autoimmunity: From Pregnancy to Cancer and Cardiovascular Disease | 5.1 | 12 | Citations (PDF) |
| 40 | Microbiome studies in the medical sciences and the need for closer multidisciplinary interplay | 5.5 | 5 | Citations (PDF) |
| 41 | Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development | 3.6 | 611 | Citations (PDF) |
| 42 | FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis | 3.6 | 225 | Citations (PDF) |
| 43 | Mucosa-associated microbiota drives pathogenic functions in IBD-derived intestinal iNKT cells | 2.6 | 32 | Citations (PDF) |
| 44 | Childhood Dietary Intake in Italy: The Epidemiological “MY FOOD DIARY” Survey | 4.7 | 24 | Citations (PDF) |
| 45 | Microbiota-gut-brain research: A plea for an interdisciplinary approach and standardization | 0.7 | 0 | Citations (PDF) |
| 46 | PARP14 Controls the Nuclear Accumulation of a Subset of Type I IFN–Inducible Proteins | 0.6 | 94 | Citations (PDF) |
| 47 | Pathogenicity of In Vivo Generated Intestinal Th17 Lymphocytes is IFNγ Dependent | 1.3 | 21 | Citations (PDF) |
| 48 | Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells | 13.9 | 269 | Citations (PDF) |
| 49 | Thymic Stromal Lymphopoietin: To Cut a Long Story Short | 5.7 | 82 | Citations (PDF) |
| 50 | The microbiota revolution: Excitement and caution | 3.2 | 32 | Citations (PDF) |
| 51 | Organ-specific protection mediated by cooperation between vascular and epithelial barriers | 56.7 | 176 | Citations (PDF) |
| 52 | Stress Exposure in Significant Relationships Is Associated with Lymph Node Status in Breast Cancer | 2.4 | 8 | Citations (PDF) |
| 53 | Abnormal thymic stromal lymphopoietin expression in the duodenal mucosa of patients with coeliac disease | 21.2 | 30 | Citations (PDF) |
| 54 | Innate and adaptive immunity in self-reported nonceliac gluten sensitivity versus celiac disease | 2.4 | 31 | Citations (PDF) |
| 55 | The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death | 39.5 | 265 | Citations (PDF) |
| 56 | Hypercoagulation and complement: Connected players in tumor development and metastases | 6.8 | 58 | Citations (PDF) |
| 57 | Coagulation induced by C3aR-dependent NETosis drives protumorigenic neutrophils during small intestinal tumorigenesis | 13.9 | 234 | Citations (PDF) |
| 58 | The variegated aspects of Immunoglobulin A | 2.5 | 5 | Citations (PDF) |
| 59 | A ‘fit’ microbiota to potentiate cancer immunotherapy | 9.7 | 10 | Citations (PDF) |
| 60 | Dendritic cell functions: Learning from microbial evasion strategies | 6.8 | 24 | Citations (PDF) |
| 61 | Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin | 6.2 | 133 | Citations (PDF) |
| 62 | BALB/c and C57BL/6 Mice Differ in Polyreactive IgA Abundance, which Impacts the Generation of Antigen-Specific IgA and Microbiota Diversity | 23.3 | 282 | Citations (PDF) |
| 63 | Intestinal microbiota and its effects on the immune system | 1.4 | 115 | Citations (PDF) |
| 64 | Oral Tolerance Can Be Established via Gap Junction Transfer of Fed Antigens from CX3CR1+ Macrophages to CD103+ Dendritic Cells | 23.3 | 434 | Citations (PDF) |
| 65 | Dendritic cell–epithelial cell crosstalk in the gut | 6.6 | 60 | Citations (PDF) |
| 66 | Lactobacillus paracasei CBA L74 Metabolic Products and Fermented Milk for Infant Formula Have Anti-Inflammatory Activity on Dendritic Cells In Vitro and Protective Effects against Colitis and an Enteric Pathogen In Vivo | 2.4 | 99 | Citations (PDF) |
| 67 | Postbiotics: what else? | 3.6 | 352 | Citations (PDF) |
| 68 | Richness of human gut microbiome correlates with metabolic markers | 38.7 | 4,289 | Citations (PDF) |
| 69 | Bacterial Sensor Triggering Receptor Expressed on Myeloid Cells-2 Regulates the Mucosal Inflammatory Response | 1.0 | 62 | Citations (PDF) |
| 70 | R5 HIV‐1 envelope attracts dendritic cells to cross the human intestinal epithelium and sample luminal virions via engagement of the CCR5 | 7.2 | 68 | Citations (PDF) |
| 71 | A Novel Method for the Culture and Polarized Stimulation of Human Intestinal Mucosa Explants | 0.3 | 10 | Citations (PDF) |
| 72 | Mucosal immunology and bacterial handling in the intestine | 3.0 | 15 | Citations (PDF) |
| 73 | Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomasBlood, 2013, 122, 705-714 | 4.2 | 92 | Citations (PDF) |
| 74 | Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model | 21.2 | 318 | Citations (PDF) |
| 75 | Dendritic cells produce TSLP that limits the differentiation of Th17 cells, fosters Treg development, and protects against colitis | 7.1 | 104 | Citations (PDF) |
| 76 | How the interplay between antigen presenting cells and microbiota tunes host immune responses in the gut | 6.8 | 47 | Citations (PDF) |
| 77 | The impact of probiotics and prebiotics on the immune system | 56.7 | 302 | Citations (PDF) |
| 78 | Vaccines in non-small cell lung cancer: Rationale, combination strategies and update on clinical trials | 5.2 | 28 | Citations (PDF) |
| 79 | Selective Infection of Antigen-Specific B Lymphocytes by Salmonella Mediates Bacterial Survival and Systemic Spreading of Infection | 2.4 | 38 | Citations (PDF) |
| 80 | The Signaling Adaptor Eps8 Is an Essential Actin Capping Protein for Dendritic Cell Migration | 23.3 | 48 | Citations (PDF) |
| 81 | The intestinal epithelial barrier in the control of homeostasis and immunity | 10.6 | 292 | Citations (PDF) |
| 82 | Systemic features of immune recognition in the gut | 2.4 | 21 | Citations (PDF) |
| 83 | Dendritic cells in oral tolerance in the gut | 1.4 | 45 | Citations (PDF) |
| 84 | Enterotypes of the human gut microbiome | 38.7 | 6,833 | Citations (PDF) |
| 85 | Gadd45α activity is the principal effector of Shigella mitochondria-dependent epithelial cell death in vitro and ex vivo | 8.7 | 24 | Citations (PDF) |
| 86 | Involvement of CD40–CD40 Ligand in Uncomplicated and Refractory Celiac Disease | 0.7 | 15 | Citations (PDF) |
| 87 | Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells | 9.4 | 611 | Citations (PDF) |
| 88 | Dendritic cells in bacteria handling in the gut | 3.0 | 13 | Citations (PDF) |
| 89 | Gut health: predictive biomarkers for preventive medicine and development of functional foods | 2.5 | 31 | Citations (PDF) |
| 90 | Functional specialization of antigen presenting cells in the gastrointestinal tract | 5.3 | 13 | Citations (PDF) |
| 91 | Dendritic cells in tolerance induction for the treatment of autoimmune diseases | 3.2 | 21 | Citations (PDF) |
| 92 | Host‐bacteria interactions in the intestine: homeostasis to chronic inflammation | 7.6 | 37 | Citations (PDF) |
| 93 | TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells | 7.4 | 158 | Citations (PDF) |
| 94 | Bacteria-Induced Gap Junctions in Tumors Favor Antigen Cross-Presentation and Antitumor Immunity | 12.7 | 194 | Citations (PDF) |
| 95 | Different Bacterial Pathogens, Different Strategies, Yet the Aim Is the Same: Evasion of Intestinal Dendritic Cell Recognition | 0.6 | 48 | Citations (PDF) |
| 96 | Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction | 21.2 | 334 | Citations (PDF) |
| 97 | Comparison of the Immunomodulatory Properties of Three Probiotic Strains of Lactobacilli Using Complex Culture Systems: Prediction for In Vivo Efficacy | 2.4 | 238 | Citations (PDF) |
| 98 | The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells | 9.4 | 93 | Citations (PDF) |
| 99 | The Gut Immune Barrier and the Blood-Brain Barrier: Are They So Different? | 23.3 | 145 | Citations (PDF) |
| 100 | Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning | 7.1 | 324 | Citations (PDF) |
| 101 | Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells | 21.2 | 344 | Citations (PDF) |
| 102 | Dendritic cells in intestinal homeostasis and disease | 10.7 | 289 | Citations (PDF) |
| 103 | Gut commensal flora: tolerance and homeostasis | 2.5 | 8 | Citations (PDF) |
| 104 | Monocyte-derived dendritic cells from Crohn patients show differential NOD2/CARD15-dependent immune responses to bacteria | 3.0 | 35 | Citations (PDF) |
| 105 | Intra‐tumoral <i>Salmonella typhimurium</i> induces a systemic anti‐tumor immune response that is directed by low‐dose radiation to treat distal disease | 3.2 | 46 | Citations (PDF) |
| 106 | Interactions among dendritic cells, macrophages, and epithelial cells in the gut: implications for immune tolerance | 5.3 | 99 | Citations (PDF) |
| 107 | Unique Role of Junctional Adhesion Molecule-A in Maintaining Mucosal Homeostasis in Inflammatory Bowel Disease | 1.0 | 235 | Citations (PDF) |
| 108 | The Biology of Intestinal Immunoglobulin A Responses | 23.3 | 519 | Citations (PDF) |
| 109 | Contrasting roles of SPARC-related granuloma in bacterial containment and in the induction of anti–<i>Salmonella typhimurium</i> immunity | 9.4 | 22 | Citations (PDF) |
| 110 | The Pathogenic Role of Intestinal Flora in IBD and Colon Cancer | 1.9 | 43 | Citations (PDF) |
| 111 | The role of altered microbial signaling via mutant NODs in intestinal inflammation | 2.3 | 17 | Citations (PDF) |
| 112 | Intestinal Bacteria Trigger T Cell-Independent Immunoglobulin A2 Class Switching by Inducing Epithelial-Cell Secretion of the Cytokine APRIL | 23.3 | 701 | Citations (PDF) |
| 113 | Entry Route of Salmonella typhimurium Directs the Type of Induced Immune Response | 23.3 | 145 | Citations (PDF) |
| 114 | Challenges and prospects of immunotherapy as cancer treatment | 7.2 | 48 | Citations (PDF) |
| 115 | Breast cancer vaccines: a clinical reality or fairy tale? | 10.2 | 80 | Citations (PDF) |
| 116 | Intravital 2-Photon Microscopy of Dendritic Cell Extension Sampling Pathogen Bacteria Into the Small Bowel Lumen | 3.0 | 0 | Citations (PDF) |
| 117 | Molecular imaging of cell-mediated cancer immunotherapy | 8.9 | 42 | Citations (PDF) |
| 118 | “Burned out” phenomenon of the testis in retroperitoneal seminoma | 1.8 | 15 | Citations (PDF) |
| 119 | Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement | 9.4 | 673 | Citations (PDF) |
| 120 | Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally differentBlood, 2005, 106, 2818-2826 | 4.2 | 147 | Citations (PDF) |
| 121 | Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells | 24.2 | 734 | Citations (PDF) |
| 122 | Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice | 2.5 | 61 | Citations (PDF) |
| 123 | Uptake and presentation of orally administered antigens | 3.2 | 24 | Citations (PDF) |
| 124 | Intestinal Epithelial Cells Control Dendritic Cell Function | 4.1 | 55 | Citations (PDF) |
| 125 | What is new in melanoma research? Vaccines, Basic and Translational Research in 2003: report of a workshop at the Third Research Meeting on Melanoma, Milan, Italy, May 2003 | 1.5 | 1 | Citations (PDF) |
| 126 | Identification of a new mechanism for bacterial uptake at mucosal surfaces, which is mediated by dendritic cells | 1.4 | 15 | Citations (PDF) |
| 127 | Lipopolysaccharide or Whole Bacteria Block the Conversion of Inflammatory Monocytes into Dendritic Cells In Vivo | 9.4 | 110 | Citations (PDF) |
| 128 | Dendritic cells and the complexity of microbial infection | 8.3 | 71 | Citations (PDF) |
| 129 | Toll-like receptor 4 is not required for the full maturation of dendritic cells or for the degradation of Gram-negative bacteria | 3.2 | 30 | Citations (PDF) |
| 130 | In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c+CD8αCD11bhigh dendritic cells | 3.2 | 50 | Citations (PDF) |
| 131 | Novel Tn antigen-containing neoglycopeptides: synthesis and evaluation as anti tumor vaccines | 2.6 | 59 | Citations (PDF) |
| 132 | Dendritic Cells Shuttle Microbes Across Gut Epithelial Monolayers | 1.1 | 268 | Citations (PDF) |
| 133 | The Host-Pathogen Interaction | 34.1 | 126 | Citations (PDF) |
| 134 | Synthesis and Biological Evaluation of an Anticancer Vaccine Containing the C-Glycoside Analogue of the Tn Epitope | 3.9 | 37 | Citations (PDF) |
| 135 | Autoreactive isotype-specific T cells determine B cell frequency | 3.2 | 4 | Citations (PDF) |
| 136 | Transcriptional reprogramming of dendritic cells by differentiation stimuli | 3.2 | 129 | Citations (PDF) |
| 137 | Differential activation of NF-κB subunits in dendritic cells in response to Gram-negative bacteria and to lipopolysaccharide | 2.4 | 54 | Citations (PDF) |
| 138 | Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria | 24.2 | 2,341 | Citations (PDF) |
| 139 | Inducible IL-2 production by dendritic cells revealed by global gene expression analysis | 24.2 | 464 | Citations (PDF) |
| 140 | Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells | 5.5 | 262 | Citations (PDF) |
| 141 | Title is missing! | 4.4 | 66 | Citations (PDF) |
| 142 | Differential effects of corticosteroids during different stages of dendritic cell maturation | 3.2 | 198 | Citations (PDF) |
| 143 | Coordinated events during bacteria-induced DC maturation | 7.7 | 196 | Citations (PDF) |
| 144 | Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: Role of opsonizing anti-?2-glycoprotein I antibodies | 6.0 | 89 | Citations (PDF) |
| 145 | Fcγ Receptor–mediated Induction of Dendritic Cell Maturation and Major Histocompatibility Complex Class I–restricted Antigen Presentation after Immune Complex Internalization | 9.4 | 855 | Citations (PDF) |
| 146 | Dendritic Cells as Natural Adjuvants | 3.6 | 16 | Citations (PDF) |
| 147 | Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells | 7.6 | 236 | Citations (PDF) |
| 148 | Maturation Stages of Mouse Dendritic Cells in Growth Factor–dependent Long-Term Cultures | 9.4 | 807 | Citations (PDF) |
| 149 | Dendritic cell maturation is required for initiation of the immune response | 3.0 | 85 | Citations (PDF) |
| 150 | Dendritic cells process exogenous viral proteins and virus‐like particles for class I presentation to CD8<sup>+</sup> cytotoxic T lymphocytes | 3.2 | 147 | Citations (PDF) |
| 151 | Retroviral immortalization of phagocytic and dendritic cell clones as a tool to investigate functional heterogeneity | 1.5 | 57 | Citations (PDF) |
| 152 | Structure of the NADPH-Binding Motif of Glutathione Reductase: Efficiency Determined by Evolution | 2.4 | 48 | Citations (PDF) |
| 153 | Mechanistic studies on Azospirillum brasilense glutamate synthase | 2.4 | 29 | Citations (PDF) |
| 154 | The kinetic mechanism of the reactions catalyzed by the glutamate synthase from Azospirillum brasilense | 0.2 | 29 | Citations (PDF) |
